Person Image

Lance Jones

Special Counsel

Corporate Advisory

Profile

Lance is a special counsel with extensive corporate law experience. He specialises in mergers and acquisitions, private equity transactions, joint ventures and shareholder arrangements, inbound overseas investment and general corporate matters for key clients of the firm. Lance is known for his technical skill, client-focused commercial approach, and his ability to lead large and complex matters and gain exceptional results. Prior to joining the firm, Lance worked for seven years in London and three years in Sydney at major international firms on cross-border M&A, private equity and capital markets transactions.

Lance is one of New Zealand's leading experts on the Overseas Investment Act, having advised on many successful applications since returning from London in 2014, and being intimately involved in the Treasury consultation process on, and preparing Russell McVeagh's and client submissions on, the multi-stage overhaul of the Act between 2018 and 2021. Lance is also a prominent member of the Overseas Investment Office's 'Legal Reference Group', with whom the OIO regularly consults on technical, policy and procedural matters.

Lance has co-authored the New Zealand Chapter for Chambers and Partners Global Practice Guide - Private Equity for the last three years (2021, 2022 and 2023), and has authored the New Zealand chapter of the global publication Lexology – Foreign Investment Review for the last five years (2020 - 2024).

Experience

Lance's recent experience includes advising:

  • I-MED on its acquisition of Taranaki Radiology.
  • A bidder for Vet Partners.
  • A bidder for Eastland Generation.
  • Fisher Funds on its acquisition of Kiwi Wealth, including obtaining Overseas Investment Office consent.
  • Lineage Logistics New Zealand on its acquisition of Cold Storage Nelson Limited.
  • I-MED on its competitive bid for, and acquisition of, Hamilton Radiology and Midland MRI, I-MED’s first major investment in radiology clinics in the New Zealand market, including obtaining Overseas Investment Office consent.
  • Pacific Equity Partners and Carlyle on New Zealand aspects of the sale of iNova Pharmaceuticals to TPG Capital.
  • Cigna on the sale of its New Zealand life insurance businesses to Chubb.
  • Clayton, Dubilier & Rice Fund XI on New Zealand aspects of its acquisition of OCS Group International, the facilities services division of OCS Group, including obtaining Overseas Investment Office consent.
  • Square, Inc (now Block, Inc) on New Zealand aspects of its acquisition of Afterpay by scheme of arrangement valued at approximately NZ41 billion on announcement, making it the largest M+A deal in Australasian history at that time, including obtaining Overseas Investment Office consent.
  • United Rentals, Inc on New Zealand aspects of its acquisition of General Finance Corporation by scheme of arrangement, including obtaining Overseas Investment Office consent.
  • Complectus Limited, on its sale of The New Zealand Guardian Trust Company and Covenant Trustee Services Limited to Tricor Group.
  • Fisher Funds Management Limited on its competitive bid for, and acquisition of, AON New Zealand's superannuation business, including the Aon New Zealand KiwiSaver scheme and Master Trust.
  • Pacific Equity Partners on New Zealand aspects of its sale of Lifehealthcare to EBOS.
  • Lineage Logistics Holdings, LLC on its acquisition of Emergent Cold from Elliot Management Corp, including obtaining Overseas Investment Office consent.
  • Keppel Infrastructure Trust on its successful competitive bid to acquire the Ixom Group (formerly Orica Chemicals) from Blackstone Private Equity for approximately A$1.1 billion, including obtaining Overseas Investment Office consent.
  • Partners Group on its investment in Invesco Asia Real Estate Fund III, L.P., including obtaining Overseas Investment Office consent.
  • Goodman Property Trust and Singaporean wealth fund GIC on their sale to Blackstone of the VXV office precinct in the Wynyard quarter for $635 million.
  • The shareholders of Complectus/Perpetual Guardian on its partial divestment to Direct Capital and related joint venture arrangements.
  • Exponent Private Equity on its acquisition of Tui Products.
  • Inenco Group Pty Ltd and SAECOWilson Limited on SAECOWilson's acquisition of the business and assets of HCD Flow Technology Limited. 
  • Spark on its acquisition of WhereScape Limited from Pioneer Capital.
  • The New Zealand Superannuation Fund on its investment in NZ Gourmet.
  • Pacific Equity Partners on its competitive bid for, and acquisition of, Academic Colleges Group, including obtaining Overseas Investment Office consent.
  • Envirowaste on its acquisition of a new cleanfill and recycling site, including obtaining Overseas Investment Office consent. 
  • Pencarrow Private Equity on its investment in Netlogix and related shareholder arrangements. 
  • The New Zealand Superannuation Fund on its investment in Lanzatech New Zealand Limited, a pre-commercialisation stage biotechnology company.

Credentials

LLB (Hons), BCom, University of Canterbury

Professional

Prior to joining Russell McVeagh in 2014, Lance worked in the corporate team at Norton Rose Fullbright in London and Herbert Smith Freehills in Sydney. He began his career at another leading New Zealand corporate law firm in 2003.

Related Expertise
Related People